Interactions between B-lymphocytes and type 1 NKT cells in autoimmune diabetes

Journal of Immunotoxicology

Volumn 5, Issue 2, 2008, Pages 249-257

  Dufour, Francois D ^a   Baxter, Alan G ^a   Silveira, Pablo A ^b  

^a JAMES COOK UNIVERSITY   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Autoimmune diabetes; B lymphocytes; Type 1 NKT cells

Indexed keywords

AUTOANTIGEN; CD1D ANTIGEN; CYCLOPHOSPHAMIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELL SPECIFICITY; DIABETES MELLITUS; DIABETOGENESIS; DISEASE PREDISPOSITION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE DEPLETION; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER T CELL; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; SPLEEN CELL;

ANIMALS; ANTIGENS, CD1; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; HUMANS; INSULIN-SECRETING CELLS; KILLER CELLS, NATURAL; MICE; MICE, INBRED NOD; SIGNAL TRANSDUCTION; SPLEEN;

EID: 45849121015     PISSN: 1547691X     EISSN: 1547691X     Source Type: Journal    
DOI: 10.1080/15476910802131543     Document Type: Review

References (120)

1. Acevedo-Suárez, C. A., Hulbert, C., Woodward, E. J., and Thomas, J. W. 2005. Uncoupling of anergy from developmental arrest in anti-insulin B-cells supports the development of autoimmune diabetes. J. Immunol. 174:827-833.
2. Akashi, T., Nagafuchi, S. Anzai, K., Kondo, S., Kitamura, D., Wakana, S., Ono, J., Kikuchi, M., and Watanabee, T. 1997. Direct evidence for the contribution of B-cells to progression of insulitis and development of diabetes in non-obese diabetic mice. Int. Immunol. 9:1159-1164.
3. + T-cell-mediated regulation and type 1 diabetes development in NOD mice. Diabetes 55:2098-2105.
4. Amano, M., Baumgarth, N., Dick, M. D., Brossay, L., Kronenberg, M., Herzenberg, L. A., and Strober, S. 1998. CD1expression defines subsets of follicular and marginal zone B-cells in the spleen: β2-microglobulin- dependent and independent forms. J. Immunol. 161:1710-1717.
5. Attavanavich, K., and Kearney, J. F. 2004. Marginal zone, but not follicular B-cells, are potent activators of naïve CD4 T-cells. J. Immunol. 172:803-811.
6. Balazs, M., Martin, F., Zhou, T., and Kearney, J. 2002 Blood dendritic cells interact with splenic marginal zone B-cells to initiate T-independent immune responses. Immunity 17:341-352.
7. - T-cell deficiency and IDDM in NOD mice. Diabetes 46:572-582.
8. Baxter, A. G., and Mandel, T. E. 1991. Haemolytic anemia in non-obese diabetic mice. Eur. J. Immunol. 21:2051-2055.
9. Bernard, N. F., Ertug, F., and Margolese, H. 1992. High incidence of thyroiditis and anti-thyroid antibobies in NOD mice. Diabetes 41:40-46.
10. Bezbradica, J. S., Stanic, A. K., Matsuki, N., Bour-Jordan, H., Bluestone, J. A., Thomas, J. W., Unutmaz, D., Van Kaer, L., and Joyce, S. 2005. Distinct roles of dendritic cells and B-cells in Vα14Jα18 natural T-cell activation in vivo. J. Immunol. 174:4696-4705.
11. Bonifacio, E., Atkinson, M., Eisenbarth, G., Serreze, D., Lee-Chan, E., and Singh, B. 2001. International workshop on lessons from animal models for human Type I diabetes: Identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in non obese diabetic mice. Diabetes 50:2451-2458.
12. Brigl, M., and Brenner, M. B. 2004. CD1: Antigen presentation and T-cell function. Annu. Rev. Immunol. 22:817-890.
13. + cytotoxic T-lymphocyte survival to enhance Type 1 diabetes. Diabetes DOI: 10.2337/db07-1256.
14. Brodnicki, T. C., O'Donnell, K., Quirk, F., and Tarlinton, D. M. 2006. Congenic non-obese diabetic mouse strains fail to confirm linkage of a marginal zone B-lymphocyte phenotype to the Idd11 locus on Chromosome 4. J. Immunol. 176:701-702.
15. H2 cytokine synthesis. Eur. J. Immunol. 29:2014-2025.
16. Cardell, S. L. 2005. The natural killer T-lymphocyte: A player in the complex regulation of autoimmune diabetes in non-obese diabetic mice. Clin. Exp. Immunol. 143:194-202.
17. + T-cells in major histocompatibility complex Class II-deficient mice. J. Exp. Med. 182:993-1004.
18. Carnaud, C., Gombert, J.-M., Donnars, O., Garchon, H. J., and Herbelin, A. 2001. Protection against diabetes and improved NK/NKT cell performance in NOD.NK1.1 mice congenic at the NK complex. J. Immunol. 166:2404-2411.
19. Carrillo, J., Puertas, M. C., Alba, A., Ampudia, R. M., Pastor, X., Planas. R., Riutort, N., Alonso, N., Pujol-Borrell, R., Santamaria, P., Vives-Pi, M., and Verdaguer, J. 2005. Islet-infiltrating B-cells in non-obese diabetic mice predominantly target nervous system elements. Diabetes 54:69-77.
20. Chen, Y. G., Choisy-Rossy, C., Holl, T. M., Chapman, H. D., Besra, G. S., Porcelli, S. A., Shaffer, D. J., Roopenian, D., Wilson, S. B., and Serreze, D. V. 2005. Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes. J. Immunol. 174:1196-1204.
21. Chen, Y. G., Driver, J. P., Silveira, P. A., and Serreze, D. V. 2007. Congenic analysis confirms genes within the Idd13 locus contributes to impaired development of invariant NKT cells in NOD mice. Immunogenetics 59:705-712.
22. Chen, Y. G., Silveira, P. A., Osborne, M. A., Chapman, H. D., and Serreze, D. V. 2007. Cellular expression requirements for inhibition of Type 1 diabetes by a dominantly protective MHC haplotype. Diabetes 56:424-430.
23. Chiu, P. P., Jevnikar, A. M., and Danska, J. S. 2001. Genetic control of T- and B-lymphocyte activation in nonobese diabetic mice. J. Immunol. 167:7169-7179.
24. Chiu, P. P., Serreze, D. V., and Danska, J. S. 2001. Development and function of diabetogenic T-cells in B-cell-deficient nonobese diabetic mice. Diabetes 50:763-770.
25. Chung, B., Aoukaty, A., Dutz, J., Terhorst, C., and Tan, R. 2005. Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. J. Immunol. 174:3153-3157.
26. Cinamon, G., Zachariah, M. A., Lam, O. M., Foss, F. W., Jr., and Cyster, J. G. 2008. Follicular shuttling of marginal zone B-cells facilitates antigen transport. Nat. Immunol. 9:54-62.
27. + T-cells to protein antigens in vivo. J. Immunol. 155:3734-3741.
28. Crowe, N. Y., Uldrich, A. P., Kyparissoudis, K., Hammond, K. J. L., Hayakawa, Y., Sidobre, S., Keating, R., Kronenberg, M., Smyth, M.J., and Godfrey, D. I. 2003. Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T-cells. J. Immunol. 171:4020-4027.
29. - T-cells. J. Exp. Med. 180:1171-1176.
30. Dobersen, M. J., Scharff, J. E., Ginsberg-Fellner, F., and Notkins, A. L. 1980. Cytotoxic autoantibodies to β cells in the serum of patients with insulin-dependent diabetes mellitus. New Engl. J. Med. 303:1493-1498.
31. Eisenbarth, G. S., Morris, M. A., and Scearce, R. M. 1981. Cytotoxic antibodies to cloned rat islet cells in serum of patients with diabetes mellitus. J. Clin. Invest. 67:403-408.
32. Esteban, L. M., Tsoutsman, T., Jordan, M. A., Roach, D., Poulton, L. D., Brooks, A., Naidenko, O. V., Sidobre, S., Godfrey, D. I., and Baxter, A. G. 2003. Genetic control of NKT cell number maps to major diabetes and lupus loci. J. Immunol. 171:2873-2878.
33. Falcone, M., Facciotti, F., Ghidoli, N., Monti, P., Olivieri, S., Zaccagnino, L., Bonifacio, E., Casorati, G., Sanvito, F., and Sarvetnick, N. 2004. Upregulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in non-obese diabetic mice.J. Immunol. 172:5908-5916.
34. Falcone, M., Lee, J., Patstone, G., Yeung, B., and Sarvetnick, N. 1998. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J. Immunol. 161:1163-1168.
35. + regulatory T-cells in the NOD mouse model of autoimmune diabetes diabetes. Proc. Natl. Acad. Sci. USA 104:18181-18186.
36. Forsgren, S., Andersson, A., Hillorn, V., Soderstrom, A., and Holmberg, D. 1991. Immunoglobulin-mediated prevention of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Scand. J. Immunol. 34:445-451.
37. Fowlkes, B. J., Kruisbick, A. M., Ton That, H., Weston, M. A., Coligan, J. E., Schwartz, R. H., and Pardol, D. M. 1987. A novel population of T-cell receptor αβ bearing thymocytes which predominantly expresses a single Vα gene family. Nature 329:251-254.
38. Fox, C. J., and Danska, J. S. 1998. Independent genetic regulation of T-cell and antigen-presenting cell participation in autoimmune islet inflammation. Diabetes 47:331-338.
39. Galli, G., Nuti, S., Tavarini, S., Galli-Stampino, L., De Lalla, C., Casorati, G., Dellabona, P., and Abrignani, S. 2003. CD1d-restricted help to B-cells by human invariant natural killer T-lymphocytes. J. Exp. Med. 197:1051-1057.
40. Galli, G., Pittoni, P., Tonti, E., Malzone, C., Uematsu, Y., Tortoli, M., Maione, D., Volpini, G., Finco, O., Nuti, S., Tavarini, S., Dellabona, P., Rappuoli, R., Casorati, G., and Abrignani, S. 2007. Invariant NKT cells sustain specific B-cell responses and memory. Proc. Natl. Acad. Sci. USA 104:3984-3989.
41. Godfrey, D. I., and Berzins, S. P. 2007. Control points in NKT cell development. Nat. Rev. Immunol. 7:505-518.
42. Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J., and Baxter, A. G. 2000. NKT cells: Facts, functions and fallacies. Immunol. Today 21:573-583.
43. - thymocytes. J. Autoimmunity 10:279-285.
44. Godfrey, D. I., and Kronenberg, M. 2004. Going both ways: Immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114:1379-1388.
45. Godfrey, D. I., MacDonald, H. R., Kronenberg, M., Smyth, M. J., and Van Kaer, L. 2004. NKT cells: What's in a name? Nat. Rev. Immunol. 4: 231-237.
46. +-like thymocytes in the NOD mouse. Eur. J. Immunol. 26:2989-2998.
47. Gray, D., McConnell, I., Kumararatne, D. S., MacLennan, I. C., Humphrey, J. H., and Bazin, H. 1984. Marginal zone B-cells express CR1 and CR2 receptors.Eur. J. Immunol. 14:47-52.
48. Greeley, S. A. W., Katsumata, M., Yu, L., Eisenbarth, G. S., Moore, D. J., Goodarzi, H., Barker, C. F., Naji, A., and Noorchasm, H. 2002. Elimination of maternally-transmitted autoantibodies prevents diabetes in non-obese diabetic mice. Nat. Med. 8:399-402.
49. Griewank, K., Borowski, C., Rietdijk, S., Wang, N., Julien, A., Wei, D. G., Mamchak, A. A., Terhorst, C., and Bendelac, A. 2007. Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 27:751-762.
50. Hammond, K. J., Pellicci, D. G., Poulton, L. D., Naidenklo, O. V., Scalzo, A. A., Baxter, A. G., and Godfrey, D. I. 2001. CD1d-restricted NKT cells: An interstrain comparison. J. Immunol. 167:1164-1173.
51. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in non-obese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.J. Exp. Med. 187:1047-1056.
52. Hong, S., Wilson, M. T., Serizawa, I., Wu, L., Singh, N., Naidenko, O., Miura, T., Haba, T., Scherer, D. C., Wei, J., Kronenberg, M., Koezuka, Y., and Van Kaer, L. 2001. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7:1052-1056.
53. Hu, C. Y., Rodriguez-Pinto, D., Du, W., Ahuja, A., Henegariu, O., Wong, F. S., Shlomchik, M. J., and Wen, L. 2007. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J. Clin. Invest. 117:3857-3867.
54. Hussain, S., and Delovitch, T. L. 2005. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B-cells is associated with increased T-cell costimulation and the development of insulitis.J. Immunol. 174:680-687.
55. cγ receptors participate in the development of autoimmune diabetes in NOD mice. J. Immunol. 179:764-774.
56. Jarpe, A., Hickman, M., Anderson, J., Winter, W., and Peck, A. 1991. Flow cytometric enumeration of mononuclear cell populations infiltrating the Islets of Langerhans in pre-diabetic NOD mice: development of a model of autoimmune insulitis for Type I diabetes. Regul. Immunol. 3:305-317.
57. Johnson, E. A., Silveira, P., Chapman, H. D., Leiter, E. H., and Serreze, D. V. 2001. Inhibition of autoimmune diabetes in non-obese diabetic mice by transgenic restoration of H2-E MHC Class II expression: Additive, but unequal, involvement of multiple APC subtypes. J. Immunol. 167:2404-2410.
58. Jordan, M. A., Fletcher, J. M., Pellicci, D., and Baxter, A. G. 2007. Slamf1, the NKT cell control gene Nkt1. J. Immunol. 178:1618-1627.
59. Kanatsuna, T., Lernmark, A., Rubenstein, A. H., and Steiner, D. F. 1981. Block in insulin release from column-perfused pancreatic β cells induced by islet cell surface antibodies and complement. Diabetes 30: 231-234.
60. Kendall, P. L., Yu, G., Woodward, E. J., and Thomas, J. W. 2007. Tertiary lymphoid structures in the pancreas promote selection of B-lymphocytes in autoimmune diabetes. J Immunol. 178:5643-5645.
61. Kitamura, D., and Rajewsky, K. 1992. Targeted disruption of μ chain membrane exon causes loss of heavy-chain allelic exclusion. Nature 356:154-156.
62. Kronenberg, M., and Gapin, L. 2002. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2:557-568.
63. Kumar, K. R., Li, L., Yan, M., Bhaskarabhatla, M., Mobley, A. B., Nguyen, C., Mooney, J. M., Schatzle, J. D., Wakel, E. K., and Mohan, C. 2006. Regulation of B-cell tolerance by the lupus susceptibility gene Ly108. Science 312:1665-1669.
64. H2 shift circumscribed regionally to the islets and functionally to islets autoantigens. J. Immunol. 166:3749-3756.
65. Laloux, V., Beaudoin, L., Ronet, C., and Lehuen, A. 2002. Phenotypic and functional differences between NKT cells colonizing splanchic and peripheral lymph nodes. J. Immunol. 168:3251-3258.
66. Lang, G. A., Devera, T. S., and Lang, M. L. 2008. Requirement for CD1d expression by B-cells to stimulate NKT cell enhanced antibody production. Blood 111:2158-2162.
67. Lang, G. A., Illarionov, P. A., Glatman-Freedman, A., Besra, G. S., and Lang, M. L. 2005. BCR targeting of biotin-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments. Int. Immunol. 17:899-908.
68. - in mice and humans.J. Exp. Med. 180:1097-1106.
69. Lehuen, A., Lantz, O., Beaudoin, L., Laloux, V., Carnaud, C., Bendelac, A., Bach, J. F., and Monteiro, R. C. 1998. Over-expression of natural killer T-cells protects Vα14-Jα 281 transgenic non-obese diabetic mice against diabetes. J. Exp. Med. 188:1831-1839.
70. Linsen, L., Somers, V., and Stinissen, P. 2005. Immunoregulation of autoimmunity by natural killer T-cells. Hum. Immunol. 66:1193-1202.
71. Mariño, E., Batten, M., Groom, J., Silveira, P., Walters, S., Liuwantara, D., Mackay, F., and Grey, S. 2005. Temporal depletion of B-cells, by selectively targeting BAFF, prevents diabetes in NOD mice. Tissue Antigens 66:488.
72. Mariño, E., Batten, M., Groom, J., Walters, S., Liuwantara, D., Mackay, F., and Grey, S. T. 2008. Marginal-zone B-cells of non-obese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. Diabetes 57:395-404.
73. Matsuki, N., Stanic, A. K., Embers, M. E., Van Kaer, L., Morel, L., and Joyce, S. 2003. Genetic dissection of Vα14Jα18 natural T-cell number and function in autoimmune-prone mice. J. Immunol. 170:5429-5437.
74. Mi, Q. S., Ly, D., Zucker, P., McGarry, M., and Delovitch, T. L. 2004. Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent Type 1 diabetes by activated CD1d-restricted invariant natural killer T-cells. Diabetes 53:1303-1310.
75. Miao, D., Yu, L., and Eisenbarth, G. S. 2007. Role of autoantibodies in Type 1 diabetes. Front. Biosci. 12:1889-1898.
76. Naumov, Y. N., Bahjat, K. S., Gausling, R., Abraham, R., Exley, M. A., Koezuka, Y., Balk, S. B., Strominger, J. L., Clare-Salzer, M., and Wilson, S. B. 2001. Activation of CD1d-restricted T-cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. USA 98:13838-13843.
77. Nichols, K. E., Hom, J., Gong, S. Y., Ganguly, A., Ma, C. S., Cannons, J. L., Tangye, S. G., Schwartzberg, P. L., Koretzky, G. A., and Stein, P. L. 2005. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat. Med. 11:340-345.
78. Noorchashm, H., Lieu, Y. K., Noorchashm, N., Rostami, S. Y., Greeley, S. A., Schlachterman, A., Song, H. K., Noto, L. E., Jevnikar, A. M., Barker, C. F., and Naji, A. 1999. I-Ag7-mediated antigen presentation by B-lymphocytes is critical in overcoming a checkpoint in T-cell tolerance to islet beta cells of non-obese diabetic mice. J. Immunol. 163:743-750.
79. Noorchashm, H., Moore, D. J., Lieu, Y. K., Noorchashm, N., Schlachterman, A., Song, H. K., Barker, C. F., and Naji, A. 1999. Contribution of the innate immune system to autoimmune diabetes:Arole for the CR1/CR2 complement receptors. Cell. Immunol. 195:75-79.
80. Noorchashm, H., Noorchashm, N., Kern, J., Rostami, S. Y., Barker, C. F., and Naji, A. 1997. B-Cells are required for the initiation of insulitis and sialitis in non-obese diabetic mice. Diabetes 46: 941-946.
81. Pasquier, B., L. Yin, M. C. Fondaneche, F. Relouzat, C. Bloch-Queyrat, N. Lambert, A. Fischer, G. de Saint-Basile, and Latour, S. 2005. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J. Exp. Med. 201:695-701.
82. + CD1d- dependent precursor stage. J. Exp. Med. 195:835-844.
83. Porcelli, S. A., and Modlin, R. L. 1999. The CD1 system: Antigen-presenting molecules for T-cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 17:297-329.
84. Poulton, L. D., Smyth, M. J., Hawke, C. G., Silveira, P., Shepherd, D., Naidenko, O. V., Godfrey, D. I., and Baxter, A. G. 2001. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int. Immunol. 13:887-896.
85. Roark, J. H., Park, S. H., Jayawardena, J., Kavita, U., Shannon, M., and Bendelac, A. 1998. CD1.1 expression by mouse antigen-presenting cells and marginal zone B-cells. J Immunol. 160:3121-3127.
86. Rocha-Campos, A. C., Melki, R., Zhu, R., Deruytter, N., Damotte, D., Dy, M., Herbelin, A., and Garchon, H. J. 2006. Genetic and functional analysis of the Nkt1 locus using congenic NOD mice: Improved Vα14-NKT cell performance but failure to protect against diabetes. Diabetes 55:1163-1170.
87. high B-lymphocytes in non-obese diabetic mice maps to diabetes susceptibility region Idd11. J. Immunol. 174:4821-4827.
88. + immunoregulatory T-cells that control autoimmune diabetes. Immunity 12:431-440.
89. Savino, W., Boitard, C., Bach, J. F., and Dardenne, M. 1991. Studies on the thymus in non-obese diabetic mouse: Changes in the microenvironmental compartments. Lab. Invest. 64:405-417.
90. null mice. J. Exp. Med. 184:2049-2053.
91. Serreze, D. V., Fleming, S. A., Chapman, H. D., Richard, S. D., Leiter, E. H., and Tisch, R. M. 1998. B lymphocytes are critical antigen-presenting cells for the initiation of T-cell-mediated autoimmune diabetes in non-obese diabetic mice.J. Immunol. 161:3912-3918.
92. Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S., Sondhi, J., Naidenko, O. V., Kronenberg, M., Koezuka, Y., Delovitch, T. L., Gombert, J. M., Leite-De-Moraes, M., Gouarin, C., Zhu, R., Hameg, A., Nakayama, T., Taniguchi, M., Lepault, F., 38. Lehuen A., Bach, J. F., and Herbelin, A. 2001. Activation of natural killer T-cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 7:1057-1062.
93. Shi, F. D., Flodstrom, M., Balasa, B., Kim, S. H., Van Gunst, K., Strominger, J. L., Wilson, S. B., and Sarvetnick, N. 2001. Germ line deletion of the CD1d locus exacerbates diabetes in the NOD mouse. Proc. Natl. Acad. Sci. USA 98:6777-6782.
94. Shimosaka, A. 2002. Role of NKT cells and alpha-galactosyl ceramide. Int. J. Hematol. 76:277-279.
95. Shortman, K., and Liu, Y. J. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:151-161.
96. Silveira, P. A., and Baxter, A. G. 2001. The NOD mouse as a model of SLE. Autoimmunity 34:53-64.
97. Silveira, P. A., Chapman, H. D., Stolp, J., Johnson, E., Cox, S. L., Hunter, K., Wicker, L. S., and Serreze, D. V. 2006. Genes within the Idd5 and Idd9/11 diabetes susceptibility loci affect the pathogenic activity of B-cells in NOD mice. J. Immunol. 177:7033-7041.
98. Silveira, P. A., Dombrowsky, J., Johnson, E., Chapman, H. D., Nemazee, D., and Serreze, D. V. 2004. B-Cell selection defects underlie the development of diabetogenic APC in non-obese diabetic mice. J. Immunol. 172:5086-5094.
99. Silveira, P. A., and Grey, S. T. 2006. B-Cells in the spotlight: Innocent bystanders or major players in the pathogenesis of Type 1 diabetes. Trends Endocrinol. Metab. 17:128-135.
100. Silveira, P. A., Johnson, E., Chapman, H. D., Bui, T., Tisch, R. M., and Serreze, D. V. 2002. The preferential ability of B-lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self antigen-specific immunoglobulin receptors. Eur. J. Immunol. 32:3657-3666.
101. H2 phenotype. J. Immunol. 163:2373-2377.
102. Sköld, M., and Behar, S. M. 2003. Role of CD1d-restricted NKT cells in microbial immunity. Infect. Immun. 71:5447-5455.
103. + T-lymphocytes directed by T-cell receptor type. Immunology 110:313-321.
104. Smyth, M. J., Crowe, N. Y., Hayakawa, Y., Takeda, K., Yagita, H., and Godfrey, D. I. 2002. NKT cells - conductors of tumor immunity? Curr. Opin. Immunol. 14:165-171.
105. Sonoda, K. H., and Stein-Streinlein, J. 2002. CD1d on antigen-transporting APC and splenic marginal zone B-cells promotes NKT cell-dependent tolerance. Eur. J. Immunol. 32:848-857.
106. Takahashi, T., and Strober, S. 2008. Natural killer T-cells and innate immune B-cells from lupus-prone NZB/W mice interact to generate IgM and IgG autoantibodies. Eur. J. Immunol. 38:156-165.
107. Tian, J., Zekzer, D., Lu, Y., Dang, H., and Kaufman, D. L. 2006. B-Cells are crucial for determinant spreading of T-cell autoimmunity among β cell antigens in diabetes-prone non-obese diabetic mice. J. Immunol. 176:2654-2661.
108. Unternaehrer, J. J., Chow, A., Pypaert, M., Inaba, K., and Mellman, I. 2007. The tetraspanin CD9 mediates lateral association of MHC Class II molecules on the dendritic cell surface.Proc. Natl. Acad. Sci USA 104:234-239.
109. Vasquez, A. C., Feili-Hariri M., Tan, R. J., and Morel, P. A. 2004. Qualitative and quantitative abnormalities in splenic dendritic cell populations in NOD mice. Clin. Exp. Immunol. 135:209-218.
110. c receptor is not expressed on Ly 1 or 'Ly 1-like' B-cells. Int. Immunol. 3:305-315.
111. Wheat, W., Kupfer, R., Gutches, D. G., Rayat, G. R., Beilke, J., Scheinman, R. I., and Wegmann, D. R. 2004. Increased NF-κB activity in B-cells and bone marrow-derived dendritic cells from NOD mice. Eur J Immunol 34:1395-1404.
112. Won, W. J., and Kearney, J. F. 2002. CD9 is a unique marker for marginal zone B-cells, B1 cells, and plasma cells in mice. J. Immunol. 168:5605-5611.
113. Wong, F. S., Visintin, I., Wen, L., Granata, J., Flavell, R., and Janeway, C. A. 1998. The role of lymphocyte subsets in accelerated diabetes in non-obese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice. J. Exp. Med. 187:1985-1993.
114. Wong, F. S., and Wen, L. 2005. B-Cells in autoimmune diabetes. Rev. Diabetic Stud. 2:121-135.
115. Wong, S., Guerder, S., Visintin, I., Reich, E. P., Swenson, K. E., Flavell, R. A., and Janeway, C. A. 1995. Expression of the co-stimulator molecule B7-1 in pancreatic β cells accelerates diabetes in the NOD mouse. Diabetes 44:326-329.
116. + T-cell levels in NOD mice. Proc. Natl. Acad. Sci. USA 99:12287-12292.
117. Yang, M., Charlton, B., and Gautam, A. M. 1997. Development of insulitis and diabetes in B-cell-deficient NOD mice. J. Autoimmun. 10:257-260.
118. H2 response and in immunoglobin E production. Sciences 270: 1845-1847.
119. nd Edition (Eisenbarth, G. S., Ed.), Austin, TX: Landes Bioscience; pp. 247-260.
120. H1-type immune responses exacerbating lupus. J. Clin. Invest. 112:1211-1222.